Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
1 other identifier
observational
75
1 country
1
Brief Summary
The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are:
- Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation?
- Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers?
- Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure? Participants will:
- Complete baseline and follow-up in-person appointments;
- Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy;
- Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2024
CompletedFirst Submitted
Initial submission to the registry
October 15, 2024
CompletedFirst Posted
Study publicly available on registry
October 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
April 22, 2026
April 1, 2026
4 years
October 15, 2024
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Digital Sensitivity for detecting gestational hypertension (HTN)
The diagnostic accuracy of the digital blood pressure cuffs will be compared to the measurements taken during in-person visits.
13 months [maximum duration of enrollment]
Secondary Outcomes (20)
Number of Participants that Complete All Surveys Between Appointments
13 months [maximum duration of enrollment]
Number of Participants That Complete All Surveys at the Baseline Appointment
13 months [maximum duration of enrollment]
Number of Participants Referred to Physicians/Care that do not have a designated provider
13 months [maximum duration of enrollment]
Number of Participants With No Comorbid Pain as Assessed by BPI-SF
13 months [maximum duration of enrollment]
Number of Participants With Mild Comorbid Pain as Assessed by BPI-SF
13 months [maximum duration of enrollment]
- +15 more secondary outcomes
Study Arms (1)
Pregnant Refugees
Participants will complete validated questionnaires, regular blood pressure measurements, pain and trauma assessments, and clinical monitoring during this study.
Interventions
Passive continuous collection of digital data (e.g., daily heart rate trends, activity levels, sleep measurements) for exploratory outcomes will occur via Apple Watches and Fitbit Versa 3s, which are synced to a smartphone application.
At-home blood pressure (BP) measurements will be weekly via a blood pressure cuff (e.g., Nokia-Withings BPM (Beats per Minute) Connect), with measurements being manually entered into the study specific smartphone app.
Eligibility Criteria
The study population is a pregnant refugee, or asylee as designated by the U.S. Government.
You may qualify if:
- Pregnant
- Refugee, asylum seeking, or asylee as designated by the U.S. Government
- Greater than or equal to 18 years of age
- Has a personal smartphone
You may not qualify if:
- Unable to provide informed consent
- Determined by the PI to be in an extremely vulnerable position and therefore not suited for research participation
- Planned move from the New York City (NYC) area within the next 24 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- National Academy of Medicinecollaborator
- Cornell Universitycollaborator
- Apple Inc.collaborator
Study Sites (1)
Weill Cornell Medicine
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gunisha Kaur, MA, MD
Weill Medical College of Cornell University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2024
First Posted
October 17, 2024
Study Start
September 12, 2024
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share